|
1
|
Döhner H, Weisdorf DJ and Bloomfield CD:
Acute myeloid leukemia. N Engl J Med. 373:1136–1152. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Döhner H, Estey EH, Amadori S, Appelbaum
FR, Büchner T, Burnett AK, Dombret H, Fenaux P, Grimwade D, Larson
RA, et al: Diagnosis and management of acute myeloid leukemia in
adults: Recommendations from an international expert panel, on
behalf of the European Leukemia Net. Blood. 115:453–474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sill H, Olipitz W, Zebisch A, Schulz E and
Wolfler A: Therapy-related myeloid neoplasms: Pathobiology and
clinical characteristics. Br J Pharmacol. 162:792–805. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Grimwade D, Hills RK, Moorman AV, Walker
H, Chatters S, Goldstone AH, Wheatley K, Harrison CJ and Burnett
AK: Refinement of cytogenetic classification in acute myeloid
leukemia: Determination of prognostic significance of rare
recurring chromosomal abnormalities among 5876 younger adult
patients treated in the United Kingdom Medical Research Council
trials. Blood. 116:354–365. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Röllig C, Bornhäuser M, Thiede C, Taube F,
Kramer M, Mohr B, Aulitzky W, Bodenstein H, Tischler HJ, Stuhlmann
R, et al: Long-term prognosis of acute myeloid leukemia according
to the new genetic risk classification of the European LeukemiaNet
recommendations: Evaluation of the proposed reporting system. J
Clin Oncol. 29:2758–2765. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang Y, Zhou Q and Ma JJ: High expression
of lnc-CRNDE presents as a biomarker for acute myeloid leukemia and
promotes the malignant progression in acute myeloid leukemia cell
line U937. Eur Rev Med Pharmacol Sci. 22:763–770. 2018.PubMed/NCBI
|
|
7
|
Garzon R, Volinia S, Papaioannou D,
Nicolet D, Kohlschmidt J, Yan PS, Mrózek K, Bucci D, Carroll AJ,
Baer MR, et al: Expression and prognostic impact of lncRNAs in
acute myeloid leukemia. Proc Natl Acad Sci USA. 111:18679–18684.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kornienko AE, Guenzl PM, Barlow DP and
Pauler FM: Gene regulation by the act of long non-coding RNA
transcription. BMC Biol. 11:592013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Anders S and Huber W: Differential
expression analysis for sequence count data. Genome Biol.
11:R1062010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ishwaran H and Kogalur UB: Consistency of
random survival forests. Stat Probab Lett. 80:1056–1064. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Heagerty PJ, Lumley T and Pepe MS:
Time-dependent ROC curves for censored survival data and a
diagnostic marker. Biometrics. 56:337–344. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Blanche P, Dartigues JF and Jacqmin-Gadda
H: Estimating and comparing time-dependent areas under receiver
operating characteristic curves for censored event times with
competing risks. Stat Med. 32:5381–5397. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Janky R, Verfaillie A, Imrichova H,
Imrichová H, Van de Sande B, Standaert L, Christiaens V, Hulselmans
G, Herten K, Sanchez Naval M, et al: iRegulon: From a gene list to
a gene regulatory network using large motif and track collections.
PLoS Comput Biol. 10:e10037312014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Su Z, Fang H, Hong H, Shi L, Zhang W,
Zhang W, Zhang Y, Dong Z, Lancashire LJ, Bessarabova M, et al: An
investigation of biomarkers derived from legacy microarray data for
their utility in the RNA-seq era. Genome Biol. 15:5232014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Díaz-Beyá M, Brunet S, Nomdedéu J,
Pratcorona M, Cordeiro A, Gallardo D, Escoda L, Tormo M, Heras I,
Ribera JM, et al: The lincRNA HOTAIRM1, located in the HOXA genomic
region, is expressed in acute myeloid leukemia, impacts prognosis
in patients in the intermediate-risk cytogenetic category, and is
associated with a distinctive microRNA signature. Oncotarget.
6:31613–31627. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cesana M, Cacchiarelli D, Legnini I,
Santini T, Sthandier O, Chinappi M, Tramontano A and Bozzoni I: A
long noncoding RNA controls muscle differentiation by functioning
as a competing endogenous RNA. Cell. 147:358–369. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Taylor J, Xiao W and Abdel-Wahab O:
Diagnosis and classification of hematologic malignancies on the
basis of genetics. Blood. 130:410–423. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
van Waalwijk van Doorn-Khosrovani
Barjesteh S, Spensberger D, de Knegt Y, Tang M, Löwenberg B and
Delwel R: Somatic heterozygous mutations in ETV6 (TEL) and frequent
absence of ETV6 protein in acute myeloid leukemia. Oncogene.
24:4129–4137. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Santos SC and Dias S: Internal and
external autocrine VEGF/KDR loops regulate survival of subsets of
acute leukemia through distinct signaling pathways. Blood.
103:3883–3889. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim DH, Lee NY, Lee MH, Sohn SK, Do YR and
Park JY: Vascular endothelial growth factor (VEGF) gene (VEGFA)
polymorphism can predict the prognosis in acute myeloid leukaemia
patients. Br J Haematol. 140:71–79. 2008.PubMed/NCBI
|
|
21
|
Lei L, Xia S, Liu D, Li X, Feng J, Zhu Y,
Hu J, Xia L, Guo L, Chen F, et al: Genome-wide characterization of
lncRNAs in acute myeloid leukemia. Brief Bioinform. Feb
15–2017.(Epub ahead of print]).
|
|
22
|
Chen ZH, Wang WT, Huang W, Fang K, Sun YM,
Liu SR, Luo XQ and Chen YQ: The lncRNA HOTAIRM1 regulates the
degradation of PML-RARA oncoprotein and myeloid cell
differentiation by enhancing the autophagy pathway. Cell Death
Differ. 24:212–224. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao TF, Jia HZ, Zhang ZZ, Zhao XS, Zou
YF, Zhang W, Wan J and Chen XF: LncRNA H19 regulates ID2 expression
through competitive binding to hsa-miR-19a/b in acute myelocytic
leukemia. Mol Med Rep. 16:3687–3693. 2017. View Article : Google Scholar : PubMed/NCBI
|
